Takeda Poised for $62 Billion Takeover of Shire

Japanese drug maker Takeda Pharmaceutical Co. has moved one step closer to acquiring a Thousand Oaks genetics laboratory owned by U.K.-based biopharmaceutical company Shire.

Amgen Pledges $750,000 to Fire and Mass Shooting Victims

Amgen Inc. has pledged a half-million dollars to help victims of the ongoing wildfires in Ventura and Los Angeles Counties, the Thousand Oaks biotech company announced Monday.

MannKind, BlackLine Report Quarterly Results

MannKind Corp. beat Wall Street estimates on earnings but missed on revenue, while BlackLine beat expectation on revenue in the third quarter.

Amgen, Dine Brands Gain After Reporting Quarterly Results

Shares of Amgen Inc. gained nearly 2 percent the day after the biotech reported third-quarter earnings, while Dine Brands Global Inc. shares gained nearly 2 percent after the company reported sales gains for its Applebee’s restaurant chain.

Second Sight Chairman Buys $4 Million in Shares

Second Sight Medical Products Inc. has entered into a stock purchase agreement with Gregg Williams, chairman of the company’s board for the purchase of nearly 2.5 million shares which will yield $4 million in proceeds to the company.

FDA Warns MannKind for ‘Misleading’ Facebook Post

The U.S. Food and Drug Administration has issued a warning letter to MannKind Corp. for sharing a misleading post about the company’s drug Afrezza on its Facebook page.

Amgen Invests $66 million in U.K. Genetics Firm

Amgen Inc. has invested $66 million in United Kingdom-based gene analysis company Oxford Nanopore, the Thousand Oaks biotech announced Thursday.

ImmunoCellular Curtails Operations, Delists From NYSE

ImmunoCellular Therapeutics Ltd. has decided to voluntarily delist its shares from the New York Stock Exchange and to significantly curtail its operations, the Calabasas biotechnology firm announced Monday.

MannKind Shares Jump 16 Percent After Finalizing Research Deal

Shares of MannKind Corp. jumped more than 16 percent Tuesday after the Westlake Village biotech finalized a previously announced agreement with United Therapeutics Corp. to develop an inhalable drug to treat a form of hypertension.

Eyenuk Expands Screening Service to Germany

Eyenuk Inc., a Woodland Hills company that uses artificial technology to screen for diabetic complications in the eyes, will expand its service to a diabetes treatment center in Germany.

Kaiser Permanente Reaches Tentative Agreement With Unions

Kaiser Permanente has reached a tentative labor agreement with an alliance of union health care workers in eight states and Washington, D.C. that includes more than 30,000 workers in Southern California.

Workers, City Settle With Canoga Park Home Care Provider

City Attorney Mike Feuer has reached a settlement with a San Fernando Valley home care provider that allegedly failed to pay its employees minimum wage and overtime.

Avita Medical Receives Australian Tax Rebate

Avita Medical Ltd. has received a $1 million tax rebate from the Australian government, the biotechnology company announced Tuesday

Avita Medical’s Burn Treatment Gets FDA Approval

The Food and Drug Administration has approved Avita Medical Ltd.’s Recell system for treating severe burns, the biotechnology company said Friday.

Amgen Partners with L.A. County on BioLA Project

Amgen Inc. has partnered with Los Angeles County to form a new organization aimed at advancing the region’s life sciences industry, the Thousand Oaks biotechnology company announced Thursday.